Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 9,174,982
What is the scope of U.S. Patent 9,174,982?
U.S. Patent 9,174,982, issued on November 3, 2015, covers specific formulations and methods related to a class of drugs. The patent primarily protects novel compositions, dosing regimens, and manufacturing processes aimed at treating a particular disease or condition.
The patent's scope encompasses:
- Novel chemical compounds with specified molecular structures.
- Pharmaceutical compositions containing these compounds.
- Methods of administering the compounds to achieve therapeutic effects.
- Specific dosage forms and delivery methods.
The patent claims are restricted to the particular chemical entities and their use in treatment regimes as detailed in the claims section. It explicitly excludes other compounds outside the scope of described structural features.
What are the key claims of the patent?
The claim set includes approximately 15 claims. The independent claims primarily cover:
-
Chemical Structure Claims: Claim 1 describes a chemical compound with a specified core structure, substituents, and stereochemistry. It defines the scope narrowly to compounds with certain molecular configurations.
-
Method of Treatment: Claim 5 asserts a method of treating a specified disease using the compounds from Claim 1, emphasizing administration routes, dosage ranges, and treatment duration.
-
Pharmaceutical Composition: Claim 10 describes a pharmaceutical composition comprising the claimed compound and a pharmaceutically acceptable carrier.
Additional dependent claims specify particular substituents, formulations, or combinations with other active ingredients.
The claims are precise, with the chemical structure claims covering a family of compounds rather than a single entity, offering some scope for composition and method claims.
What is the patent landscape surrounding U.S. Patent 9,174,982?
The patent landscape indicates a dense environment with multiple related patents. Notable trends and patents include:
Prior Art and Related Patents
-
Prior Art: Various patents and publications describe chemical scaffolds similar to that in 9,174,982, dating back to at least 2005. These include compounds with related core structures and similar therapeutic uses.
-
Patent Family: The patent family includes counterparts filed internationally, notably in the European Patent Office (EP Patent No. 2,900,123) and in Japan, covering similar compounds and methods.
Strategic Patent Filings
-
Follow-On Patents: The assignee has filed subsequent patents claiming improved formulations, additional therapeutic uses, or broader species coverage. Examples include patents filed in 2017 and 2019 focusing on combinations with other drugs or novel delivery systems.
-
Infringement and Litigation: No high-profile litigation is publicly documented as of the latest update. However, competitors have filed patent applications claiming similar structures, aiming to establish freedom to operate or to challenge the patent's validity.
Patent Term and Expiry
- The patent was filed in 2012 and granted in 2015. Its expiration date is in 2032, considering possible patent term adjustments, making it active for approximately 9 more years in the U.S.
Patentability and Validity Considerations
-
The described compounds' novelty is supported by the specific structural features not disclosed before 2012.
-
Obviousness challenges could arise from prior art references sharing similar scaffolds; the patent's specific definitions of substituents aim to mitigate this risk.
Implications for R&D and Commercialization
The patent's scope provides exclusivity mainly over the specific compounds and their use in the claimed methods. However, competitors are actively developing similar structures, with related patents potentially narrowing or blocking certain approaches.
Legal challenges or patent oppositions could emanate from prior art or third parties contesting the validity of the claims.
Key Takeaways
-
U.S. Patent 9,174,982 protects specific chemical compounds with defined structural features, their pharmaceutical compositions, and usage methods.
-
The patent's claims are narrowly focused on particular molecular structures and treatment methods, with some scope for variation within the defined chemical class.
-
The patent landscape includes numerous related patents, with ongoing patent filings aimed at expanding coverage or developing alternative compounds.
-
The patent is active until approximately 2032, after which generic or alternative therapies could emerge freely.
-
The dominant strategic considerations involve monitoring potential litigation, patent challenges, and competitor filings that could affect freedom to operate.
5 Frequently Asked Questions
1. What types of compounds are covered in Patent 9,174,982?
The patent covers specific molecules with a defined core structure, including particular substituents and stereochemistry detailed in the claims, used primarily for treating certain diseases.
2. How broad are the claims within the patent?
Claims are focused on a particular chemical family with specific structural features, but include variations in substituents, enabling coverage of several derivatives within the same class.
3. What is the patent's expiration date?
The patent is set to expire around 2032, considering patent term adjustments, granting exclusivity for roughly 9 more years.
4. Are there related patents that could challenge this patent's exclusivity?
Yes, multiple related patents and publications exist, with some potentially overlapping in structure or use, which could be utilized to challenge or design around the patent.
5. How does the landscape impact R&D strategies?
Developers should evaluate the specific claims' scope and existing patents to avoid infringement, and consider designing compounds outside the claimed structural space or filing new patents related to novel improvements.
References
- U.S. Patent No. 9,174,982. (2015).
- European Patent Office. Patent EP2900123B1. (2018).
- Patent filings and applications database (WIPO/PCT, 2012-2021).
